Walder Wyss advises Boehringer Ingelheim, while VISCHER AG advised NBE-Therapeutics on the deal. Homburger advised PPF Group. Boehringer Ingelheim and the shareholders of NBE-Therapeutics have signed…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
